Knee osteoarthritis injection study halted early
NCT ID NCT04931667
First seen Apr 09, 2026 · Last updated May 08, 2026 · Updated 4 times
Summary
This study tested an injection called lorecivivint for people with knee osteoarthritis. The goal was to see if it safely eases pain and improves knee function over three years in a real-world setting. The study was stopped early and included 72 adults aged 40 to 80.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS OF THE KNEE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Tucson, Arizona, 85712, United States
-
Research Site
Winter Park, Florida, 32789, United States
-
Research Site
Oak Brook, Illinois, 60523, United States
-
Research Site
Dallas, Texas, 75231, United States
Conditions
Explore the condition pages connected to this study.